Patterns of care in adjuvant systemic therapy of patients with stage III melanoma: A U.S. population-based study.
Scientists at the Icahn School of Medicine at Mount Sinai have developed a novel artificial intelligence (AI) tool that not only identifies disease-causing genetic mutations but also predicts the type ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results